Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Rockville
State: Maryland
Zip:
Country: United States
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem&s;s research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/29/2006
Ticker Symbol:
SNCA
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Post-IPO Equity | $7.5M | 1/2010 | Post-IPO Equity | $1.5M | 12/2016 | Post-IPO Equity | 1 | $20M |
Tianjin Pharmaceutical Group International Holdings Tianjin Pharmaceutical Group International Holdings |
3/2013 | Post-IPO Debt | 1 | $8M |
Hercules Capital Hercules Capital |
5/2016 | Post-IPO Equity | $1.1M | 4/2013 | Post-IPO Equity | $1.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|